Medicine Grand Rounds on Friday, August 19, 2016 for the presentation titled:

“Eosinophilic Esophagitis: A Novel Food Allergy”

8:00 a.m. – 9:00 a.m.

Auditorium E, Rubin Building, Dartmouth-Hitchcock Medical Center

Co-Sponsored by the Section of Allergy and the Department of Medicine
The Geisel School of Medicine at Dartmouth

Objectives – Participants will be able to:
1.    Describe new knowledge of Eosinophilic Esophagitis (EoE)
2.    Evaluate treatment options for EoE 
3.    Assess the role of food allergy in EoE 

Dr. Spergel is a Professor of Pediatrics at the University of Pennsylvania School of Medicine and Chief of the Allergy Section at Children’s Hospital of Philadelphia.  He is also holder of the Stuart Starr Chair of Pediatrics and Director of The Center for Eosinophilic Diseases. He received his medical and graduate education at the Mount Sinai School of Medicine and completed his pediatric residency at Yale-New Haven Hospital.  His clinical and post-graduate research training in Allergy and Immunology were completed at Children’s Hospital, Harvard Medical School, Boston, MA.  Dr. Spergel is Board Certified in Pediatrics and Allergy and Immunology. He is a fellow in the American Academy of Allergy, Asthma and Immunology (AAAAI), the American College of Allergy, Asthma and Immunology, the American Association of Pediatrics, Philadelphia College of Physicians and others. He has served on national and international committees on food allergy, atopic dermatitis and eosinophilic esophagitis and is the principal investigator for multiple studies in these fields. He has published over 120 articles and has spoken nationally and internationally on these topics.

His current research in Eosinophilic Esophagitis focuses on clinical matters (desensitization and tolerance), food allergy and translational research (molecular mechanisms). In particular, his research explores the role of fibrosis, iNKT cells, microbiome and genetic pathways. 

Dr. Spergel reported potential conflicts of interest with NIH, FARE, Almmune Therapeutics, Dannone and DBV Technology. The conflicts of interest have been resolved by validating the activity content through independent peer review.

If you are unable to attend and would like to either view Grand Rounds live on your computer or if you would like to view it another time, please use this link. 

http://med.dartmouth-hitchcock.org/education/dept_medicine_grand_rounds_live.html

Please note: in order to receive credit for attending this conference you must complete the mobile sign-in within 48 hours of the presentation. Use the text-in number 603-346-4334 from your phone or enter the activity code from a computer http://www.d-h.org/clpd-account

Activity Codes will not be provided until the time of the presentation. Please email Jessica Kinzie with questions Jessica.d.kinzie@hitchcock.org

The office of Continuing Medical Education will not be able to give you credit unless you use the mobile sign in. If you need to claim credit more than 48 hours after the conference you will need to contact clpd.support@hitchcock.org.

** The Dartmouth-Hitchcock Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education programs for physicians.**

** The Dartmouth-Hitchcock Medical Center designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. **